We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-1.15%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.4B
AUM Growth
+$334M
Cap. Flow
+$578M
Cap. Flow %
4%
Top 10 Hldgs %
50.45%
Holding
913
New
139
Increased
302
Reduced
176
Closed
73

Sector Composition

Rank Sector Weight
1 Energy 58.22%
2 Healthcare 2.73%
3 Financials 2.71%
4 Materials 2.68%
5 Consumer Discretionary 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNK icon
151
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.24B
$3.85M 0.03%
34,907
-100,562
-74% -$11.1M
GWPH
152
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.7M 0.03%
28,041
+3,120
+13% +$367K
CLVS
153
DELISTED
Clovis Oncology, Inc.
CLVS
$3.69M 0.03%
+54,314
New +$3.8M
MUX icon
154
McEwen Inc
MUX
$1.03B
$3.58M 0.02%
156,862
+35,251
+29% +$712K
PAGP icon
155
Plains GP Holdings
PAGP
$5.23B
$3.57M 0.02%
162,730
+18,654
+13% +$393K
PTLA
156
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.52M 0.02%
72,306
+15,518
+27% +$785K
FWONA icon
157
Liberty Media Series A
FWONA
$22.3B
$3.5M 0.02%
111,654
+26,932
+32% +$921K
GFI icon
158
Gold Fields
GFI
$29.2B
$3.47M 0.02%
807,453
-214,103
-21% -$863K
Y
159
DELISTED
Alleghany Corp
Y
$3.41M 0.02%
+5,719
New +$3.26M
LSXMA
160
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$3.29M 0.02%
114,745
+19,447
+20% +$586K
LGND icon
161
Ligand Pharmaceuticals
LGND
$6.02B
$3.2M 0.02%
37,488
+4,461
+14% +$387K
HALO icon
162
Halozyme
HALO
$9.72B
$3.2M 0.02%
157,748
+17,984
+13% +$331K
META icon
163
Meta Platforms (Facebook)
META
$1.51T
$3.14M 0.02%
17,790
+6,201
+54% +$1.1M
MINT icon
164
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$3.09M 0.02%
30,408
+75
+0.2% +$7.63K
CODI icon
165
Compass Diversified
CODI
$755M
$3.08M 0.02%
181,950
+2,550
+1% +$43.8K
AGIO icon
166
Agios Pharmaceuticals
AGIO
$2.16B
$3.05M 0.02%
53,416
+5,943
+13% +$374K
AUY
167
DELISTED
Yamana Gold, Inc.
AUY
$2.96M 0.02%
947,794
-351,573
-27% -$939K
FTAI icon
168
FTAI Aviation
FTAI
$22.2B
$2.85M 0.02%
167,336
+45,714
+38% +$717K
SPG icon
169
Simon Property Group
SPG
$74.5B
$2.84M 0.02%
16,519
+274
+2% +$44.5K
ARRY
170
DELISTED
Array Biopharma Inc
ARRY
$2.79M 0.02%
218,328
+49,485
+29% +$563K
LOXO
171
DELISTED
Loxo Oncology, Inc
LOXO
$2.79M 0.02%
33,080
+3,679
+13% +$307K
IMMU
172
DELISTED
Immunomedics Inc
IMMU
$2.72M 0.02%
+168,456
New +$1.99M
JPM icon
173
JPMorgan Chase
JPM
$939B
$2.72M 0.02%
25,403
+11,147
+78% +$1.13M
EBS icon
174
Emergent Biosolutions
EBS
$375M
$2.7M 0.02%
58,094
+5,283
+10% +$222K
NG icon
175
NovaGold Resources
NG
$2.6B
$2.67M 0.02%
679,490
-84,362
-11% -$336K

Similar funds

ALPS Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, ALPS Advisors held 913 positions worth $14.4B, up 2.4% from $14.1B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

ALPS Advisors deployed $578M of net new capital in Q4 2017, opening 139 new positions and adding to 302 existing holdings. Its largest new stake was NGL Energy Partners: 9,255,792 shares worth $130M.

By sector, the portfolio is most concentrated in Energy at 58% of assets, down from 58% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was T. Rowe Price, an estimated $53.8M trimmed.

  • ALPS Advisors's largest Q4 2017 buy was NGL Energy Partners: 9,255,792 shares worth $130M.
  • ALPS Advisors added most to Energy Transfer Partners, L.P. in Q4 2017, an estimated $112M increase.
  • ALPS Advisors's biggest Q4 2017 reduction was T. Rowe Price, cutting an estimated $53.8M.
  • ALPS Advisors fully exited The Mosaic Company in Q4 2017, selling an estimated $50.4M.
  • ALPS Advisors's ten largest holdings make up 50% of its $14.4B portfolio in Q4 2017.
  • ALPS Advisors opened 139 new positions and closed 73 in Q4 2017.
  • ALPS Advisors's portfolio value rose 2.4% quarter-over-quarter to $14.4B.

Based on ALPS Advisors's 13F filing for Q4 2017, filed 5 Feb 2018.